Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-102.02%
operating margin TTM
-71.58%
revenue TTM
197.92 Million
revenue per share TTM
3.35$
valuation ratios | |
|---|---|
| pe ratio | -1.54 |
| peg ratio | 0.01 |
| price to book ratio | 1.04 |
| price to sales ratio | 1.58 |
| enterprise value multiple | -3.21 |
| price fair value | 1.04 |
profitability ratios | |
|---|---|
| gross profit margin | 93.15% |
| operating profit margin | -71.58% |
| pretax profit margin | -64.16% |
| net profit margin | -102.02% |
| return on assets | -45.09% |
| return on equity | -49.24% |
| return on capital employed | -45.0% |
liquidity ratios | |
|---|---|
| current ratio | 2.39 |
| quick ratio | 2.38 |
| cash ratio | 0.58 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 45.69 |
| operating cycle | 137.87 |
| days of payables outstanding | 172.62 |
| cash conversion cycle | -34.75 |
| receivables turnover | 3.96 |
| payables turnover | 2.11 |
| inventory turnover | 7.99 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.03 |
| debt equity ratio | 0.05 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.05 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -7.01 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.87 |
| cash per share | 4.46 |
| operating cash flow per share | -1.85 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -7.01 |
| short term coverage ratios | -19.70 |
| capital expenditure coverage ratio | -109.66 |
Frequently Asked Questions
When was the last time Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) reported earnings?
Vanda Pharmaceuticals Inc. (VNDA) published its most recent earnings results on 30-10-2025.
What is Vanda Pharmaceuticals Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)'s trailing twelve months ROE is -49.24%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Vanda Pharmaceuticals Inc. (VNDA) currently has a ROA of -45.09%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did VNDA's net profit margin stand at?
VNDA reported a profit margin of -102.02% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is VNDA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.39 in the most recent quarter. The quick ratio stood at 2.38, with a Debt/Eq ratio of 0.05.